NGF is implicated in retinal damage regression. To study whether this is a direct effect or an effect mediated by NGF on other endogenous biological mediators, we investigated the effect of exogenous administration of NGF in RCS rats affected by retinitis pigmentosa. We found that NGF administration exerts a rescue effect on photoreceptors in this animal model. NGF injection enhances brain-derived neurotrophic factor, b-fibroblast growth factor, transforming growth factor-b, vascular endothelial factor and neuropeptide-Y. This suggests that NGF has an effect on RCS rat retina, probably also through the stimulation of other biological mediators produced and released in the retina.
Introduction
A number of recent studies have reported that the differentiation, survival and function of retinal cells are regulated by survival growth factors, including neurotrophins (Bagnoli, Dal Monte, & Casini, 2003; Chaum, 2003; Dyer & Cepko, 2001; Frade, Bovolenta, & Rodriguez-Tebar, 1999) . We previously reported that injection of NGF in CH3 mice delayed retinal degeneration and suggested that a deficit in the synthesis and/or release of NGF might be implicated in the mechanism leading to retinal degeneration (Lambiase & Aloe, 1996) . This hypothesis is supported by our recent studies showing that cells of the visual system of Royal College of Surgeons (RCS) rats affected by inherited retinal cell degeneration (Gal et al., 2000) are characterized by a significant reduction of both NGF protein and mRNA (Amendola & Aloe, 2002; Amendola, Fiore, & Aloe, 2003) . Moreover, studies published in recent years have raised the question of the efficacy of a single growth factor and hypothesized the possibility of the overlapping and/or cascading effects triggered by one growth factor on other growth factors can enhance the survival of injured of retinal cells (Chaum, 2003; Ogilvie, Speck, & Lett, 2000) . Nonetheless, whether NGF has a direct effect on retinal cells or acts indirectly by stimulating the synthesis and release of other growth factors has not been clearly established.
Evidence obtained in animals with experimentally induced retinal cell degeneration and in rodents with inherited retinal deficit, indicated that a number of soluble factors, including brain derived neurotrophic factor (BDNF) factor a (TNF-a), vascular endothelial factor (VEGF), and neuropetide-Y (NPY) can, alone or together with other growth factors, protects retinal cell degeneration through mechanisms not yet clearly identified (Aloe et al., 2001; Chaum, 2003; Dunker, Schuster, & Krieglstein, 2001; Witmer, Vrensen, Van Noorden, & Schlingemann, 2003) . The aims of the present investigation were to study the effect of NGF on photoreceptors survival and on growth factors that have been suggested to be involved in retinal cell development and retinal cell survival, (Faktorovich, Steinberg, Yasumura, Matthes, & LaVail, 1990; Liu & Regillo, 2004) . To test our hypothesis, NGF was injected in the retrobulbar space of RCS rats during the third week of life. We selected this stage on the basis of our previous studies indicating that the degeneration of outer nuclear layer (ONL) in the retina of RCS rats takes place between the second and third week of life and that this structural ONL reduction is associated with a steady decrease of NGF (Amendola & Aloe, 2002) . The results of the present study indicate that the administration of NGF during this critical period of retinal degeneration retards retinal cell death and enhances the expression of other survival growth factors produced locally. The possible functional significance of these findings will also be discussed.
Materials and methods

Animals
The RCS rats were originally obtained from Dr. R. Hanitzsch from the Carl Ludwig Institute of Physiology, University of Leipzig, Germany, and raised in our stabularium as reported (Hanitzsch, Zeumer, Lichtenberger, & Wurziger, 1998) . All the rats used in our studies were maintained on a 12 h light/dark cycle and provided with food and water ad libitum. They were all killed in the morning between 10:00 am and 12:00 am.
As regards housing, care and experimental procedures we followed the indications set out by the Ethical Commission on animal sperimentation of the CNR (1992) in conformity with National and International laws (EEC council directive 86/609, OJ L 358, 1, December 12, 1987) . Moreover, all efforts were made to minimize animal suffering and to reduce the number of animals used.
Chemicals
The NGF was isolated from the mouseÕs submandibular gland according to Bocchini and Angeletti method (Bocchini & Angeletti, 1969) . Polyclonal anti-mouse NGF antibodies were prepared in rabbit, purified by a process of affinity chromatography and characterized as described (Stoeckel, Gagnon, Guroff, & Thoenen, 1976) .
Treatments
Soon after delivery the number of newborn RCS rats of each litter (n = 10) was reduced to 8 pups. Under these conditions, pups develop somatic markers, such as eyelid opening, tooth eruption and fur growth, at the same age. At 18 days of age each litter was divided in two experimental groups of four rats each. The first group of four rats received retrobulbar administration of 5 lg of purified NGF dissolved in 5 ll of (0.09% NaCl) physiological saline (PS), or 5 lg of cytochrome C, a protein with the physiochemical properties and molecular weight of NGF, but lacking biological activity (Aloe et al., 2001 ) diluted in 5 ll of PS, as controls. All chemicals were delivered using a Hamilton microliter syringer (Bonaduz, Switzerland) equipped with a needle gauge 26 s. To assess whether the effect of NGF was due to injury-related effect, five rats received the dry needle, (size as above), insertion into the retrobulbar region and the concentration of b-FGF, VEGF, TrkA and TNF-a was measured.
To further investigate the role of NGF in the retina, other rats (n = 8/group) received intravitreal administration of 10 lg of affinity purified murine anti-NGF antibodies raised in goat, dissolved in 5 ll of PS, or of 10 lg of goat IgG, diluted in 5 ll of PS, and used as control. As an additional control, a group of rats (n = 6) of the same age received intravitreal insertion of a dry needle.
The rats were treated every-other day for 8 days and at 27 days of age they received an overdose of carbon dioxide and their eyes were removed and used for structural, immunohistochemical, biochemical and molecular analysis of the retina.
Morphological and Immunofluorescence analysis
Eye bulbs were removed, fixed with 4% paraformaldehyde dissolved in 0.1 M phosphate buffer, pH 7.4, for 24 h and then left overnight in the same buffer containing 20% of sucrose. The eyes were then sectioned with a cryostate at 20 lm thick. The sections were cut along the vertical meridian to include the full length of the retina from the optic nerve head to the ora serrata. Sections (n = 10) of each NGF-treated and untreated rats, immunostained for the presence of NGF receptor or stained with toluidine blue (not shown), were used for a quantitative analysis to determine the mean thickness of the ONL layer. The value of the ONL thickness was obtained after measuring eight different fields of each retina under a Zeiss Axiphot microscope equipped with a 20· objective with the aid of a computerized image analysis system.
Effect of NGF on distribution of blood vessels in the retina
The retinas of the RCS rats treated with NGF, anti-NGF-antibodies and respective controls were mounted flat on glass slides, air dried, and labeled with biotinylated Griffonia simplicifolia lectin B4 (Vector Laboratories, CA, USA). The retinas were then exposed to rhodamine-conjugated avidin (Vector Laboratories, CA, USA). The stained retinas were then analyzed under a Nikon microscope equipped with software LUCIA for the quantitative evaluation of stained vessels. Blood vessels present in 50 different fields of different retina (n = 10) were counted and compared.
NGF assay
Retinas were homogenated and centrifuged at 8500 g for 30 min. Polystyrene 96-well microtubes immunoplates (Nunc) were coated with affinity purified polyclonal goat anti-NGF antibody, diluted in 0.05 M carbonate buffer (pH 9.6). Parallel wells were coated with purified goat IgG (Zymed, San Francisco, CA, USA), for the evaluation of the non-specific signal. Following an overnight incubation at room temperature and 2 h incubation with a blocking buffer (0.05 M carbonate buffer, pH 9.5, 1% BSA), the plates were washed three times with Tris-HCl, pH 7.4 50 mM, NaCl 200 mM, 0.5% gelatin, 0.1% Triton X-100. After extensive washing of the plates, the samples and the NGF standard solution were diluted with a sample buffer (0.1% Triton X-100, 100 mM Tris-HCl, pH 7.2, 400 mM NaCl, 4 mM EDTA, 0.2 mM PMSF, 0.2 mM benzethonium chloride, 2 mM benzamidine, 40 U/ml aprotinin, 0.05% sodium azide, 2% BSA and 0.5% gelatin), distributed into the wells and left at room temperature overnight. The plates were then washed three times and incubated with 4 mU/well anti-fl-NGF-galactosidase (Boehringer Mannheim, Germany) for 2 h at 37°C and, after further washing, 100 ll of substrate solution (4 mg/ml of chlorophenol red, Boehringer Mannheim, Germany, substrate buffer: 100 mM HEPES, 150 mM NaCl, 2 mM MgCl 2 , 0.1% sodium azide and 1% BSA) was added to each well. After an incubation of 2 h at 37°C, the optical density was measured at 575 nm, using an ELISA reader (Dynatech), and the values of standards and samples were corrected by taking into consideration the non-specific binding. Under these conditions the sensitivity was 3 pg/ml and the recovery of NGF in our assay ranged from 80% to 90%. The recovery was estimated by adding to the retina extracts a known amount of purified NGF and the yield of the exogenous NGF was calculated by subtracting the amount of this NGF from the endogenous NGF. Data were represented as pg/g wet weight and all assays were performed in triplicate.
TGF-b1 protein determination
The quantification of TGF-b1 was performed by using a two-site enzyme immunoassay kit (DuoSet), from R&D (Minneapolis, MN, USA) and following the manufacturerÕs instructions. TGF-b1 concentration in the retina was expressed as pg/gr wet and all assays were performed in triplicate.
Western blotting analysis for TrkA, TNF-a, VEGF and b-FGF
The retinal tissue was homogenized in sample buffer (0.01 M TRIS-HCl buffer pH 7.6, containing 0.25 M sucrose, 0.1 M NaCl, 1 mM EDTA, and 1 mM PMSF) and centrifuged at 8000g for 10 min at 4°C. The supernatants were then used for western blotting. The samples (30 lg total protein) were dissolved with a loading buffer (0.1 M TRIS-HCl buffer (pH 6.8) containing 0.2 M DTT, 4% SDS, 20% glycerol, and 0.1% bromophenol blue), separated by 12.5% SDS-PAGE, and electrophoretically transferred to a polyvinylidene fluoride membrane (PVDF) for 3 h. The membranes were incubated for 40 min at room temperature with a blocking buffer (10% non-fat dry milk, 10 mM TRIS pH 7.5, 100 mM NaCl, 0.1% Tween 20) and washed three times for 10 min each at room temperature in Tris-buffered saline and Tween (TTBS) (10 mM TRIS pH 7.5, 100 mM NaCl, 0.1% Tween 20). This was followed by an incubation of 2 h at room temperature with anti-TNF-a 1:500, anti-TrkA 1:500, anti-b FGF 1:1000 (provided by SantaCruz, CA, USA) anti-VEGF 1:500 (provided by Chemicon International, CA, USA). The membranes were then washed three times for 10 min each at room temperature in TTBS and incubated for 1 h with horseradish peroxydase-conjugated anti-rabbit IgG (Cell Signalling, Beverly, MA, USA) as the secondary antibody. The blots were developed with an enhanced chemiluminescent (ECL) assay (Amersham Bioscience, UK limited, England) as the chromophore. The optical density of b-actin bands was used as an internal control for difference in sample loading.
RT-PCR ELISA
mRNA expression levels were measured using a standardized RT-PCR method as previously described (Tirassa, Manni, Stenfors, Lundeberg, & Aloe, 2000) . Briefly, the total RNA was extracted from the retina by using the Chomczynski and Sacchi method (1987) as modified in the TRIzol Kit (Gibco). Complementary DNA (cDNA) was synthesized from 2 lg of the total RNA using 200 Units of M-MLV reverse transcriptase (Promega Italia, Milano, Italy) in 20 ll of total volume reaction containing 250 ng Oligo (dT) 12-18 primer, 0.5 Units RNasin ribonuclease inhibitor and 0.5 mM dNTP in 5· Reaction Buffer (250 mM Tris-Cl pH 8.3; 375 mM KCl; 15 mM MgCl 2 ; 50 mM DTT). The mixture was incubated at 42°C for 1 h and the reaction was terminated with a further incubation at 95°C for 5 min.
The housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), was co-amplified with TrkA, BDNF, b-FGF, VEGF, NPY and used to normalize sample to sample variability. PCR amplification was carried out using a 50 ll reaction mixture containing: cDNA, 5 ll in 10· buffer, 200 mM dNTPs, 1.5 mM MgCl 2 , 2.5 Units of Taq 0 ; 5 0 -GGGACAGGCAGACTGGTTTC-3 0 ) and 3.12 pmol of GAPDH primers (5 0 -CACCACCATG-GAGAAGGCC-3 0 ; 5 0 -CACCACCATGGAGAAGGC-C-3 0 ). To allow the detection of PCR product by ELISA, biotinylated primers were used. A sample containing all the reaction reagents except cDNA was used as PCR negative control in any amplification. Ten microlitres of 1:10 RT mixture without enzyme were used as further PCR negative control. The mixtures were incubated for the indicated cycles consisted of 1 min at 95°C, 1 min at 55°C and 2 min at 72°C for 35 cycles in a GeneAmp PCR System 9700 (Applied Biosystems, CA, USA). The PCR products were electrophorized in 2% agarose gel together with a DNA ladder of 100 base pairs (GIBCO) and visualized by ethidium bromide.
To assess the presence of these probes, the microplates (Maxisorp Nunc) were coated with 50 lg/ml of avidin (Sigma Chemical, Italy) in a coating buffer (15 mM Na 2 CO 3 , 35 mM NaHCO 3 , pH 9.6), and incubated for 2 h at 37°C. After incubation free sites were saturated with 2% blocking solution (Boheringer Mannheim) in a coating buffer. Biotinylated PCR products diluted in PBS containing 3% Bovine Serum Albumin (PBSB) were distributed in triplicate (100 ll/well) in avidin-coated microplates and incubated for 1 h at room temperature. After incubation the microplates were washed three times with PBS containing 0.02% Tween 20 (a washing buffer). The DNA was denatured using 0.25 M NaOH at room temperature for 10 min, then 100 ll/well of 4 pmol/ml digoxygenin-labelled probes of TrkA (5 0 -TGAAGTACTGTGGGTTCTC-
0 ) and GAPDH (5 0 -ACAATCTTGAG-TGAGT-TGTCATATTTCTCG-3 0 ) in DIG Easy Hybri-dization buffer (Boehringer Mannheim) were added and incubated at 42°C for 2 h. After washing, anti-digoxygenin PODcoupled antibody (Boehringer Mannheim) was added (1:1000 in PBSB) and incubated for 1 h at 37°C. The reaction was developed by TMB (3,3 0 ,5,5 0 -tetramethylbenzidine; 0.6 mg in citrate buffer, pH 5.0) and blocked after 30 min with 2 M HCl. The amount of amplified products was measured as optical density at 450/690 nm (OD, 450/690) using a Dynatech ELISA Reader 5000. GAPDH (OD, 450/690) level was used to normalize the relative differences in sample size, integrity of the individual RNA and variations in reverse transcription efficiency.
Statistical analysis
The analysis of variance (ANOVA) was used to analyze ONL thickness and neurotrophins, growth factors and cytokines levels in the retinas of the RCS rats. Post hoc comparisons within logical sets of means were performed using the Tukey-Kramer test.
Results
General observations
No somatic differences were found between NGFtreated and anti-NGF treated RCS rats compared to respective controls. Body weight, time of eye opening, tooth eruption, and weaning schedules were not different. Moreover, the mean weight of the eye cup was similar between groups (data not shown).
Effect of NGF on TrkA in the retina
To explore whether retinal cells were receptive to NGF, NGF or anti-NGF antibody were injected in the retrobulbar and intravitreal region.
The results show that injection of NGF causes a marked increase of TrkA protein in the retinal tissues of the RCS rats as shown in Fig. 1A . NGF administration also induces an upregulation of TrkA mRNA levels in the retinas of the RCS rats (Fig. 1B) , compared to cytochrome C treated rats (p < 0.05).
This observation is consistent with other previous reports which showed that retinal cells are receptive to the action of NGF (Amendola et al., 2003) .
Effect of NGF on ONL thickness
NGF untreated RCS rats show a progressive reduction of the ONL leading to retinal degeneration. The thickness of ONL was measured and used as an index of photoreceptor loss of the retina in treated and un-treated RCS rats. The average ONL width of the NGF treated RCS ratsÕ retinas was 81.8 ± 2.44 lm, while it was 56.3 ± 3.71 lm (p < 0.01) in the untreated retinas and 30.4 ± 6.17 lm (p < 0.0001) in the anti-NGF treated retinas. In the IgG-treated retinas it was 59.5 ± 10.26 lm, as shown in Fig. 2. 
Effect of NGF on retinal blood vessels
Since retinal cell survival is associated with the presence of blood vessels, the retinas of NGF-treated and untreated rats were isolated and used to evaluate the distribution of retinal blood vessels. As reported in Fig. 3A and B, NGF reduces the loss of blood vessels in the retina of RCS rats, and, as shown in Fig. 3C , this difference is statistically significant (p < 0.01).
Effect of NGF or anti-NGF administration on retinal BDNF presence
Because BDNF has been shown to be involved in promoting the recovery of injured retinal cells (Krueger-Naug, Emsley, Myers, Currie, & Clarke, 2003), we tested the effect of NGF administration on BDNF presence. As shown in Fig. 4A , NGF enhances the concentration of BDNF protein compared with the control retinas. This effect seems functionally relevant, since anti-NGF administration down-regulates BDNF gene expression (p < 0.05, Fig. 4B ).
Effect of NGF or anti-NGF administration on b-FGF presence
As shown in Fig. 5A and B, the retrobulbar administration of NGF causes an increase in b-FGF protein and mRNA expression compared to cytochrome C injected retinas, while the administration of anti-NGF antibodies leads to a decrease of b-FGF gene expression, compared to IgG injected rats (p < 0.01, Fig. 5C ).
Effect of NGF or anti-NGF administration on retinal NPY presence
NPY is a neuropeptide that has been shown to be present in retinal tissues and the brainÕs visual projection (Aloe et al., 2001) . As reported in Fig. 6A and B, the administration of NGF enhances gene expression, while the anti-NGF antibody reduces it. This difference is statistically significant (p < 0.05).
Effect of NGF or anti-NGF administration on retinal VEGF presence
VEGF has also been found in the retina and it is known to promote the development of rat photoreceptor cells (Witmer et al., 2003) . As reported in Fig. 7 , the administration of NGF causes an increase in both VEGF protein (Fig. 7A) and VEGF gene expression (Fig. 7B ) in the retina of RCS rats and this difference is statistically significant compared to control (p < 0.05). (B) show respectively western blot analysis and RT-PCR ELISA for VEGF in the retina of RCS rats treated either with cytochrome C or NGF. Data on the VEGF mRNA expression represent mean levels ± SD. Asterisks indicate significant differences between the two groups (p < 0.05). Both VEGF mRNA and protein increased after the treatments.
Effect of NGF on TGF-b level
TGF-b is a survival factor present in the retina that has been tested for treatment of macular holes and as survival factor on in vitro retinal cells (Dunker et al., 2001; Glaser, Michels, Kuppermann, Sjaarda, & Pena, 1992) . As reported in Fig. 8A , an immunoenzymatic analysis showed that treatment with NGF causes a statistically significant (p < 0.01) increase of TGF-b protein in the retina of the RCS rats.
Effect of NGF on TNF-a level
To investigate whether an injection of NGF enhanced the expression of pro-inflammatory cytokines, we tested the effect of NGF on the presence of TNF-a. As shown in Fig. 8B , NGF has no effect on TNF-a protein release.
Effect of dry needle injection
Since it has been reported that needle insertion in the subretinal region can produce a rescue effect on photoreceptor cells (Faktorovich, Steinberg, Yasumura, Matthes, & LaVail, 1992) , we measured the concentration of TrkA, b-FGF, VEGF and TNF-a in rats receiving only a dry needle injection in the retrobulbar or intravitreal regions. As reported in Fig. 9 , western blotting analysis revealed that retinal injury induced by retrobulbar (NI-R) or intravitreal (NI-I) dry needle insertion, did not cause TrkA, b-FGF, VEGF and TNF-a protein increase.
Discussion
The purpose of the present study was twofold: first to investigate the effect of retrobulbar administration of NGF on photoreceptor cell survival and second, to explore whether the administration of NGF influences the local synthesis and release of other growth factors involved in the survival and function of the retinal cells. The results demonstrated that injection of NGF enhances the expression of high-affinity NGF receptor proteins and of their mRNA in the retina of RCS rats, suggesting that retinal cells are receptive to the action of NGF. Moreover, it was found that the administration of NGF, given during a critical stage of retinal degeneration, could significantly reduce retinal cell death. Thus the evidence that NGF stimulates the synthesis and release of other endogenous growth factors, including b-FGF, BDNF, TGF-b and VEGF, known to be involved in the delay or prevention of retinal cell degeneration, support the hypothesis of the role of NGF as cell retinal survival factor. The immunohistochemical analysis performed on NGF-treated and untreated rats indicated that the photoreceptor layer and the ONL thickness are larger than those of NGF-untreated rats, suggesting as previously reported that NGF given to CH3 mice (Lambiase & Aloe, 1996) and to RCS rats (Amendola & Aloe, 2002; Amendola et al., 2003) protects the retinal cells from degeneration. This hypothesis is strengthened by the observation that administration of anti-NGF antibody, which inhibits the biological activity of the endogenous produced NGF, exacerbates the degenerative course of RGCs (Lambiase & Aloe, 1996) . Our findings also showed that NGF injection causes not only an increase of the FGF-b, BDNF, VEGF proteins, but also an overexpression of their m-RNAs. This effect seems functionally relevant, since the administration of anti-NGF antibodies significantly reduces the expression of these growth factors in the retina. Moreover, we found that NGF stimulates retinal TGF-b and NPY, but not TNF-a, a pro-inflammatory cytokine also present in the retina. Further evidence suggesting a functional role of NGF on retinal cells, is that the administration of NGF protects blood vessels loss in the retinas of the RCS rats. The effect of NGF on vascular endothelial cells and blood vessels has been recently reported, both in rodents (Emanueli et al., 2002) and in humans (Foster, Costa, Poston, Hoult, & Brain, 2003) .
It has been reported that retinal injury caused by needle insertion can also affect the synthesis and release of growth factors and to rescue damaged photoreceptors (Faktorovich et al., 1992) . The observation that dry needle insertion by itself does not reproduce the effect of NGF on b-FGF, VEGF, TrkA, suggests that the effect of NGF on these survival factors are due to NGF but not to retinal injury (Faktorovich et al., 1992) . This hypothesis is also suggested by evidence that NGF administration and needle insertion do not stimulate TNF-a release.
We have previously shown that NGF can delay retinal cell degeneration in C3H mice and that early NGF treatment induces a delay in the evolution of retinal degeneration, significantly increasing the thickness of the ONL and reducing the extension of retinal degeneration (Lambiase & Aloe, 1996) . The fact that NGF undergoes a dramatic decrease during postnatal life in the retina of RCS rats (Amendola et al., 2003) and that the administration of NGF during a critical period of retinal cell degeneration delays cell death (Lambiase & Aloe, 1996) indicates that NGF loss might be one cause or a contributing factor of retinal degeneration. The mechanism through which NGF exerts its survival action is not clearly known. As NGF is known to play a marked role in the prevention of cell apoptosis, our working hypothesis is that NGF acts on the modulation of other survival factors, such as b-FGF, NPY, VEGF, TGF-b, BDNF. The observation that NGF exerts a protective and/or survival action on retinal cells is in line with other previous findings (Amendola et al., 2003; Lambiase & Aloe, 1996; Siliprandi, Canella, & Carmignoto, 1993) . It is therefore possible that the administration of NGF during a critical period of retinal cell degeneration, alone or in combination with other biological mediators, might delay retinal cell death in genetic and not genetically induced retinal cell degeneration. Using this or other animal models of RP, it would be of interest to determine whether or not a prolonged NGF exposure and/or the co-administration of multiple factors could provide additional synergistic benefits.
